Vnitr Lek 2011, 57(9):755-759

Plypharmacy and drug interactions

J. Suchopár*, M. Prokeš
Infopharm, a.s., Praha, předseda představenstva PharmDr. Josef Suchopár

The growing consumption of drugs and other numerous factors relates to the increasing incidence of polypharmacy. The proportion of patients currently treated with 5 or more medicines at the elderly population in particular is 30-60% of patients. Repeatedly has been proven the dependence between the number of concomitant drugs and occurrence of adverse effects, patients requiring hospitalization, or incidence of moderate and serious drug interactions. Some works show that it is possible to satisfactorily address the issues of polypharmacy, but it requires great courage and an interdisciplinary approach involving modern information technology.

Keywords: drug consumption; polypharmacy; drug interactions

Received: May 11, 2011; Published: September 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Suchopár J, Prokeš M. Plypharmacy and drug interactions. Vnitr Lek. 2011;57(9):755-759.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Smečka V, Kolář J. Lékárenství - Lékárenská činnost výdejní I. 1. vyd. Brno: Professio-nal Publishing 2000.
    2. Veehof L, Stewart R, Haaijer-Ruskamp F et al. The development of polypharmacy. A longitudinal study. Fam Pract 2000; 17: 261-267. Go to original source... Go to PubMed...
    3. Kennerfalk A, Ruigómez A, Wallander MA et al. Geriatric drug therapy and health care utilization in the United Kingdom. Ann Pharmacother 2002; 36: 797-803. Go to original source... Go to PubMed...
    4. Viktil KK, Blix HS, Moger TA et al. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problem. Br J Clin Pharmacol 2006; 63: 187-195. Go to original source... Go to PubMed...
    5. Gurwitz JH. Polypharmacy. A new paradigm for quality drug therapy in the elderly? Arch Intern Med 2004; 164: 1957-1958. Go to original source... Go to PubMed...
    6. Junius-Walker Theile G, Hummers-Pradier E. Prevalence and predictors of polypharmacy among older primary care patients in Germany. Fam Pract 2007; 24: 14-19. Go to original source... Go to PubMed...
    7. Rottlaender D, Scherner M, Schneider T et al. Polypharmacy, compliance and non-prescription medication in patients with cardiovascular disease in Germany. Dtsch Med Wochenschr 2007; 132: 139-144. Go to original source... Go to PubMed...
    8. Legemiddelindustriforeningen. Facts and Figures 2006. Oslo: LMI 2006.
    9. ÚZIS ČR. Zdravotnictví jako součást národní ekonomiky 2009. Časové řady vybraných finančních ukazatelů. ÚZIS 2010: 50.
    10. Hovstadius B, Hovstadius K, Astrand B et al. Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol 2010; 10: 16-24. Go to original source... Go to PubMed...
    11. Leendertse AJ, Egberts AC, Stoker LJ et al. HARM Study Group. Frequency of and Risk Factors for Preventable Medication-Related Hospital Admissions in the Netherlands. Arch Intern Med 2008; 168: 1890-1896.
    12. Garfinkel D, Zur-Gil S, Ben-Israel J. The war against Polypharmacy: A New Cost-Effective Geriatric-Palliative Approach for Improving Drug Therapy in Disabled Elderly People. Isr Med Assoc J 2007; 9: 430-434. Go to PubMed...
    13. Johnell K, Klarin I. The Relationship between Number of Drugs and Potential Drug-Drug Interactions in the Elderly. A Study of Over 600,000 Elderly Patients from the Swedish Prescribed Drug Register. Drug Saf 2007; 30: 911-918. Go to original source... Go to PubMed...
    14. Fialová D, Topinková E, Gambassi G et al. AdHOC Project Research Group. Potentially Inappropriate Medication Use Among Elderly Home Care Patients in Europe. JAMA 2005; 293: 1348-1358. Go to original source... Go to PubMed...
    15. Topinková E, Mádlová P, Fialová D et al. Nová evidence-based kritéria pro posouzení vhodnosti lékového režimu u seniorů. Kritéria STOPP (Screening Tool of Older Person's Prescritption) a START (Screening Tool to Alert Doctors to Right Treatment). Vnitř Lék 2008; 54: 1161-1169. Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.